HORMONAL-REGULATION OF MITOGEN-ACTIVATED PROTEIN-KINASE ACTIVITY IN BOVINE ADRENOCORTICAL-CELLS - CROSS-TALK BETWEEN PHOSPHOINOSITIDES, ADENOSINE-3',5'-MONOPHOSPHATE, AND TYROSINE KINASE RECEPTOR PATHWAYS

Angiotensin-II (AII), which stimulates steroidogenesis in bovine adrenocortical (BAC) cells through the phosphoinositides pathway, activates p42-p44 mitogen-activated protein kinases (MAPKs) after 5 min of treatment (EC(50) = 0.1 nM). This activation is 1) completely inhibited by the AII receptor AT(1) subtype antagonist Dup 753 (10 mu M)I but unaffected by the AT(2) antagonist PD 123177; 2) not reproduced by the AT(2) agonist CGP 42112A; 3) insensitive to pretreatment with pertussis toxin; and 4) abolished by a 48-h preexposure of the cells to the phorbol ester 12-O-tetradecanoylphorbol 13-acetate (TPA; 1 mu M), which down-regulates protein kinase-C activity. Fibroblast growth factor-2, a potent mitogen far BAC cells, which acts through its tyrosine kinase receptor, also activates MAPK (EC(50) = 0.3 ng/ml) in a TPA-insensitive manner, while exhibiting no detectable effect on BAC cell steroidogenesis. In contrast, ACTH, which stimulates steroidogenesis via cAMP and inhibits BAC cell proliferation, does not stimulate MAPK. Indeed, ACTH completely blocks (IC50 = 0.01 nM) the stimulation of MAPK by AII, fibroblast growth factor-2, or TPA. Therefore, bovine adrenocortical cells provide an example of positive and negative hormonal regulation of MAPK activity through a cross-talk between the inositide-, cAMP-, and growth factor-activated tyrosine kinase pathways.